- ICH GCP
- Register voor klinische proeven in de VS.
- Klinische proef NCT00042198
Treatment of Depression After Coronary Bypass Surgery
Studie Overzicht
Toestand
Conditie
Interventie / Behandeling
Gedetailleerde beschrijving
Depression is a very common problem for people who have had CABG surgery, and recent studies have shown that it may increase the risk of additional medical problems and death during the first few years after surgery. Cognitive behavior therapy (CBT) has been shown to be efficacious for depression in otherwise healthy individuals, and supportive stress management (SSM) interventions have also been shown to improve depressive symptoms. These therapies have not, however, been tested for depression in individuals who have undergone CABG surgery.
Participants will be screened for depression within 1 year after CABG surgery. Those who have depression will return for additional testing 1 week later. Eligible participants will be randomized to receive CBT, SSM, or usual care (UC), with no restrictions on nonstudy antidepressants, for 12 weeks. Patients will be monitored for worsening depression referred for additional care if needed. Depression, anxiety, and health-related quality of life will be assessed at baseline, 12 weeks after randomization, and 6 months after surgery (2 months after termination of CBT or SSM).
Studietype
Inschrijving (Werkelijk)
Fase
- Niet toepasbaar
Contacten en locaties
Studie Locaties
-
-
Missouri
-
St. Louis, Missouri, Verenigde Staten, 63108
- Washington University School of Medicine
-
-
Deelname Criteria
Geschiktheidscriteria
Leeftijden die in aanmerking komen voor studie
Accepteert gezonde vrijwilligers
Geslachten die in aanmerking komen voor studie
Beschrijving
Inclusion Criteria:
- Coronary Artery Bypass Graft (CABG) surgery (alone or combined with valvular or carotid surgery) within past 12 months
- Meets DSM-IV criteria for major or minor depressive episode
Exclusion Criteria:
- Severe cognitive impairment
- Severe psychiatric comorbidity (e.g., alcoholism or schizophrenia)
- Severely debilitating or life-threatening illness other than coronary disease
Studie plan
Hoe is de studie opgezet?
Ontwerpdetails
- Primair doel: Behandeling
- Toewijzing: Gerandomiseerd
- Interventioneel model: Parallelle opdracht
- Masker: Enkel
Wapens en interventies
Deelnemersgroep / Arm |
Interventie / Behandeling |
---|---|
Experimenteel: 1
Cognitive Behavior Therapy.
The treatment modality was individual, face-to-face therapy with an experienced cognitive therapist.
Treatment consisted of up to 12 weekly, hour-long sessions.
|
Up to 12 weekly, individual, hour-long sessions
|
Actieve vergelijker: 2
Supportive Stress Management.
The treatment modality was individual, face-to-face therapy with an experienced psychotherapist.
Treatment consisted of up to 12 weekly, hour-long sessions.
|
Up to 12 weekly, individual, hour-long sessions, focusing on application of relaxation and other stress management techniques to depressogenic stressors
|
Geen tussenkomst: 3
Usual Care, minimally enhanced.
Participants in all three arms were given information about depression.
There were no restrictions in any of the arms on usual care for depression, heart disease, or any other conditions, except that concurrent participation in nonstudy psychotherapy was not allowed.
Participants were allowed to continue or start on nonstudy antidepressants during the study, as prescribed by the participant's personal physician.
|
Wat meet het onderzoek?
Primaire uitkomstmaten
Uitkomstmaat |
Maatregel Beschrijving |
Tijdsspanne |
---|---|---|
Hamilton Rating Scale for Depression (HAM-D-17)
Tijdsspanne: 12 weeks post-randomization
|
The HAM-D-17 is an observer-rated measure of the severity of depression.
|
12 weeks post-randomization
|
Secundaire uitkomstmaten
Uitkomstmaat |
Maatregel Beschrijving |
Tijdsspanne |
---|---|---|
Beck Depression Inventory
Tijdsspanne: 12 weeks post-randomization
|
The BDI is a self-report measure of the severity of depression.
|
12 weeks post-randomization
|
Beck Anxiety Inventory
Tijdsspanne: 12 weeks post-randomization
|
The BAI is a self-report measure of the severity of anxiety symptoms.
|
12 weeks post-randomization
|
Beck Hopelessness Scale
Tijdsspanne: 12 weeks post-randomization
|
The BHS is a self-report measure of hopelessness.
|
12 weeks post-randomization
|
Perceived Stress Scale
Tijdsspanne: 12 weeks post-randomization
|
The PSS is a self-report measure of perceived stress
|
12 weeks post-randomization
|
SF-36
Tijdsspanne: 12 weeks post-randomization
|
The Medical Outcomes Study SF-36 is a measure of health-related quality of life.
The Physical and Mental factor scores will be reported.
|
12 weeks post-randomization
|
Medewerkers en onderzoekers
Medewerkers
Onderzoekers
- Hoofdonderzoeker: Kenneth E Freedland, Ph.D., Washington University School of Medicine
Publicaties en nuttige links
Studie record data
Bestudeer belangrijke data
Studie start
Primaire voltooiing (Werkelijk)
Studie voltooiing (Werkelijk)
Studieregistratiedata
Eerst ingediend
Eerst ingediend dat voldeed aan de QC-criteria
Eerst geplaatst (Schatting)
Updates van studierecords
Laatste update geplaatst (Schatting)
Laatste update ingediend die voldeed aan QC-criteria
Laatst geverifieerd
Meer informatie
Termen gerelateerd aan deze studie
Trefwoorden
Aanvullende relevante MeSH-voorwaarden
Andere studie-ID-nummers
- R01MH060735 (Subsidie/contract van de Amerikaanse NIH)
- DSIR AT-AS
Deze informatie is zonder wijzigingen rechtstreeks van de website clinicaltrials.gov gehaald. Als u verzoeken heeft om uw onderzoeksgegevens te wijzigen, te verwijderen of bij te werken, neem dan contact op met register@clinicaltrials.gov. Zodra er een wijziging wordt doorgevoerd op clinicaltrials.gov, wordt deze ook automatisch bijgewerkt op onze website .
Klinische onderzoeken op Cognitive behavior therapy
-
Utah State UniversityOnbekendTrichotillomanieVerenigde Staten
-
Chestnut Health SystemsNational Institute on Drug Abuse (NIDA)VoltooidDrugsmisbruik | Substantie afhankelijkheidVerenigde Staten
-
Hospices Civils de LyonWervingHyperekplexieFrankrijk
-
Medical University of South CarolinaNational Institute on Deafness and Other Communication Disorders (NIDCD)Actief, niet wervendHartinfarct | Afasie | Afasie niet vloeiendVerenigde Staten
-
Rhode Island HospitalSynovation Medical GroupWerving
-
Columbia UniversityBeëindigd
-
Cyberonics, Inc.Voltooid
-
Shanghai Ninth People's Hospital Affiliated to...Werving
-
AxomoveWerving
-
Western University, CanadaBeëindigdStressstoornissen, posttraumatischCanada